1.湖南中医药大学第一附属医院,湖南省长沙市雨花区韶山中路95号,410007
2.湖南中医药大学
yxlshh@126.com
收稿:2023-04-13,
修回:2023-08-30,
纸质出版:2023-12-02
移动端阅览
李江伟,张艳雪,彭静娴等.彭清华分期辨治自身免疫性葡萄膜炎经验[J].中医杂志,2023,64(23):2393-2396.
LI Jiangwei,ZHANG Yanxue,PENG Jingxian,et al.Peng Qinghua's Experience in the Staged Treatment of Autoimmune Uveitis[J].Journal of Traditional Chinese Medicine,2023,64(23):2393-2396.
李江伟,张艳雪,彭静娴等.彭清华分期辨治自身免疫性葡萄膜炎经验[J].中医杂志,2023,64(23):2393-2396. DOI: 10.13288/j.11-2166/r.2023.23.004.
LI Jiangwei,ZHANG Yanxue,PENG Jingxian,et al.Peng Qinghua's Experience in the Staged Treatment of Autoimmune Uveitis[J].Journal of Traditional Chinese Medicine,2023,64(23):2393-2396. DOI: 10.13288/j.11-2166/r.2023.23.004.
总结彭清华教授分期辨治自身免疫性葡萄膜炎的临证经验。认为自身免疫性葡萄膜炎病机总属本虚标实,以正气亏虚为本、风湿瘀胶结为标。临证根据疾病不同阶段进行分期辨证治疗,急性期以正气亏虚、风湿瘀胶结为关键病机,治宜益气活血、祛风除湿,自拟益气活血祛风除湿方;缓解期以脾肾亏虚为关键病机,治宜调补脾肾、益精明目,自拟益精明目汤。推崇早期干预,既病防变,阻断病势,常合用中成药正清风痛宁缓释片,并提倡生活调摄,预防复发。
This paper summarized clinical experience of Professor Peng Qinghua in the staged treatment of autoimmune uveitis (AU). The pathogenesis of AU is always based on root-cause deficiency and manifestation excess, with weakness of healthy
qi
as the root, and accumulation of wind, dampness and blood stasis as the minifestation. Syndrome differentiation and treatment is usually carried out according to different stages of disease. During the acute stage, deficiency of healthy
qi
and stagnation of wind-dampness are the key pathomechanisms, so the treatment is to replenish
qi
and activate blood, dispel wind and remove dampness, and self-made
Yiqi Huoxue Qufeng Chushi Decoction
(益气活血祛风除湿方) can be used. During remission stage, deficiency of spleen and kidney is the key mechanism, so the treatment is to tonify the spleen and kidney, replenish the essence and brighten the eyes, and self-made
Yijing Mingmu Decoction
(益精明目汤) can be used. Meanwhile, it was recommened to treat early, prevent and interrupt the disease, commonly combine with Chinese patent medicine
Zhengqing Fengtongning tablets
(正清风痛宁缓释片), and promote regulation of living to prevent recurrence.
TSIROUKI T , DASTIRIDOU A , SYMEONIDIS C , et al . A focus on the epidemiology of uveitis [J]. Ocul Immunol Inflamm , 2018 , 26 ( 1 ): 2 - 16 .
GÓMEZ-GÓMEZ A , MADRID-GARCIA A , BORREGO-SANZ L , et al . Therapeutic response after immunosuppressive drug prescription in non-infectious uveitis:a survival analysisc [J]. Ophthalmol Ther , 2023 , 12 ( 1 ): 139 - 153 .
HUANG C , ZHANG Z , GU J , et al . Combined therapy of experimental autoimmune uveitis by a dual-drug nanocomposite formulation with berberine and dexamethasone [J]. Int J Nanomedicine , 2023 , 18 : 4347 - 4363 . doi: 10.2147/IJN.S417750 http://dx.doi.org/10.2147/IJN.S417750 .
WU X , TAO M , ZHU L , et al . Pathogenesis and current therapies for non-infectious uveitis [J]. Clin Exp Med , 2023 , 23 ( 4 ): 1089 - 1106 .
许馨月 , 何伟 . 中医治疗葡萄膜炎研究进展 [J]. 实用中医内科杂志 , 2021 , 35 ( 5 ): 133 - 136 .
裴超 , 刘静霞 . 复方目炎宁联合激素治疗复发性葡萄膜炎的临床研究 [J]. 黑龙江医学 , 2018 , 42 ( 3 ): 240 - 242 .
王琦妙 , 庞雅菊 , 李岩 , 等 . 益气调血方药治疗葡萄膜炎黄斑囊样水肿的临床观察 [J]. 中国中医眼科杂志 , 2018 , 28 ( 3 ): 163 - 167 .
王琦妙 , 张远龙 , 庞雅菊 . 实验性自身免疫性葡萄膜炎的中医药干预研究进展 [J]. 现代中西医结合杂志 , 2022 , 31 ( 7 ): 1015 - 1019 .
智宇星 , 李红梅 , 徐安龙 . 中西医学视角下对免疫的再认识:基于辨证论治和免疫态的讨论 [J]. 中医杂志 , 2022 , 63 ( 21 ): 2001 - 2008 .
DEWISPELAERE R , LIPSKI D , FOUCART V , et al . ICAM-1 and VCAM-1 are differentially expressed on blood-retinal barrier cells during experimental autoimmune uveitis [J]. Exp Eye Res , 2015 , 137 : 94 - 102 . doi: 10.1016/j.exer.2015.06.017 http://dx.doi.org/10.1016/j.exer.2015.06.017 .
金善善 , 许文成 , 王小琴 . 从炎症细胞因子探讨中医风邪致病的物质基础 [J]. 中华中医药学刊 , 2019 , 37 ( 1 ): 67 - 69 .
金明柱 , 郑洪新 . 中医药干预糖皮质激素副作用的研究 [J]. 辽宁中医药大学学报 , 2007 , 9 ( 2 ): 23 - 24 .
魏聪 , 常丽萍 , 李翠茹 , 等 . 通络养生理论探讨 [J]. 中医杂志 , 2021 , 62 ( 6 ): 463 - 467 .
曾志成 , 彭清华 . 正清风痛宁缓释片替代激素治疗前葡萄膜炎临床观察 [J]. 中医药导报 , 2008 , 14 ( 8 ): 62 - 63 .
0
浏览量
0
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号